AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03050606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates
Description: Exercises performed on the mat and apparatus, following the six principles of the Pilates method. The exercises will be performed in three levels of difficulty: basic, intermediate and advanced, according to the capacity of the patient.
Study NCT03050606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic
Description: Aerobic exercise will be carried out individually on treadmills or stationary bikes. The intensity of the training will be mild to moderate (57% to 76% of the maximal heart rate monitored by the frequencymeter).
Study NCT03823898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Description: Two supervised exercise sessions per week from months 4 to 16
Study NCT03823898 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle intervention from baseline to 4 months
Description: Lifestyle intervention from baseline to 4 months
Study NCT03823898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention from baseline to 4 months
Description: Lifestyle intervention from baseline to 4 months
Study NCT03823898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monthly behavioral sessions
Description: Monthly behavioral sessions consisted of lifestyle interactive sessions will take place monthly and covered and followed contents that were addressed during the first 4 months of the study
Study NCT02408484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Octafibrin
Description: Plasma-derived Fibrinogen concentrate
Study NCT03671642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Q-ICG
Description: Quantitative perfusion assessment with indocyanine green on a touch screen tablet
Study NCT03671642 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: White light perfusion assessment
Description: Traditional visual perfusion assessment in white light
Study NCT03671642 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fluorescence angiography
Description: Perfusion assessment with fluorescence angiography - without quantification
Study NCT02054936 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rivaroxaban (Xarelto)
Description: To date there has been little attention to evaluating differences in wound complications following TJA among patients treated with rivaroxaban compared to warfarin.
Study NCT02054936 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin (Coumadin)
Description: To date there has been little attention to evaluating differences in wound complications following TJA among patients treated with rivaroxaban compared to warfarin.
Study NCT00488059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enfuvirtide [Fuzeon]
Description: 90 mg SC twice daily
Study NCT00488059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimized background ARV
Description: As prescribed
Study NCT00488059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Integrase inhibitor
Description: As prescribed
Study NCT00488059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enfuvirtide [Fuzeon]
Description: 180 mg SC once daily
Study NCT04762264 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ProFlor inguinal hernia device
Description: Device follow up after inguinal hernia repair with ProFlor
Study NCT04053218 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Exercise plus omega-3 supplement
Description: Supervised aerobic exercise and omega-3 supplement
Study NCT04053218 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Olive oil placebo
Study NCT02625389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lipiodol® Ultra Fluid with surgical glues
Description: Lipiodol® Ultra Fluid and surgical glue mixture may vary from 20 to 80% and should be administered via selective arterial catheterization only.
Study NCT03329664 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cytokine-induced killer cell
Description: Immune-cell therapy with CIK cells
Study NCT03329664 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chemotherapy AND/OR Radiation Therapy
Description: Routine treatments for colon cancer patients according to their stage
Study NCT03329664 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy AND/OR Radiation Therapy
Description: Routine treatments for colon cancer patients according to their stage
Study NCT03238079 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 10% IGIV
Description: 300-900 mg/kg
Study NCT01665898 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cold Biopsy forceps
Description: removal of polyps using cold biopsy forceps
Study NCT01665898 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cold snare biopsy
Description: Removal of colon polyps using cold snare biopsy
Study NCT03408288 — intervention group
Intervention type: OTHER
Intervention: Hemapoche
Description: Use of Hemapoche scale to assess hematuria in reference samples
Study NCT03408288 — intervention group
Intervention type: OTHER
Intervention: Hemastick
Description: Use of Hemastick scale to assess hematuria in reference samples
Study NCT03408288 — intervention group
Intervention type: OTHER
Intervention: Color description
Description: Describe color of reference sample
Study NCT04771104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Amino Acid Challenge (AAC)
Description: The AAC contains 54 g banana flavoured amino acid mixture added 200-300 mL of water. The AAC simulates the composition of haemoglobin in approximately 400 mL of blood.
Study NCT04771104 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Amino Acid Challenge (AAC)
Description: The AAC contains 54 g banana flavoured amino acid mixture added 200-300 mL of water. The AAC simulates the composition of haemoglobin in approximately 400 mL of blood.
Study NCT04583345 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires: Physical therapists ask questions these assess quality of life, anxiety and depression, physical activity level.
Study NCT00662727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec)
Description: Energy Density - 0.09 mJ/mm2
Study NCT00662727 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04433065 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intrepid™ TTVR System
Description: Device: Intrepid™ TTVR System
Study NCT05028881 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: blood sampling for determining antibody responses
Study NCT05119153 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Placebo designed to mimic coffee color.
Study NCT05119153 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Light Roasted Coffee
Description: 12 oz light roast coffee
Study NCT05119153 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Medium Roasted Coffee
Description: 12 oz medium roast coffee
Study NCT05119153 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dark Roasted Coffee
Description: 12 oz dark roast coffee
Study NCT02074917 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anatomical ACL reconstruction
Description: Anatomical anterior cruciate ligament reconstruction in the anteromedial or central tunnels positions.
Study NCT02677714 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 99mTc-rhAnnexin V-128
Description: Kit for the preparation of 99mTc-rhAnnexin V-128
Study NCT03639454 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dry needling
Description: Dry needling, also known as myofascial trigger point dry needling, is an well-proved technique in alternative medicine similar to acupuncture. It involves the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain, including pain related to myofascial pain syndrome. Dry needling is sometimes also known as intramuscular stimulation (IMS).
Study NCT03639454 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Description: Transcutaneous electrical nerve stimulation (TENS or TNS) is the use of electric current produced by a device to stimulate the nerves for therapeutic purposes.~TENS, by definition, covers the complete range of transcutaneously applied currents used for nerve excitation although the term is often used with a more restrictive intent, namely to describe the kind of pulses produced by portable stimulators used to treat pain. The unit is usually connected to the skin using two or more electrodes. A typical battery operated TENS unit is able to modulate pulse width, frequency and intensity. Generally TENS is applied at high frequency (>50 Hz) with an intensity below motor contraction (sensory intensity) or low frequency (\<10 Hz) with an intensity that produces motor contraction.
Study NCT04100863 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: There is no intervention for this study.
Study NCT02930967 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous CSR T
Description: Patients will be received a three-day regimen of chemotherapy consisting of cyclophosphamide aimed to deplete the lymphocytes. 1 to 4 days after lymphodepletion, a prescribed dose of CSR T cells will be intravenously infused to patient in a three-day split-dose regimen (day0,10%; day1, 30%; day2, 60%).
Study NCT06425497 — intervention group
Intervention type: OTHER
Intervention: The dosage of dnDSA
Description: Flow cytometric analysis using FlowPRA Screening Test and/or Luminex Single Antigen Beads class I and II- IgG (cut- positivity off = MFI> 1000)
Study NCT01796938 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide tablet
Description: Single dose of 100 mg Lacosamide tablet
Study NCT02996214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel Liposome
Description: Paclitaxel liposome injection 175 mg/m\^2, given on day 1 of a 21-day cycle, for 4-6 cycles.
Study NCT02996214 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine 1000 mg/m\^2, given on days 1 and 8 of a 21-day cycle, for 4-6 cycles.
Study NCT02996214 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin 75 mg/m\^2, given on day 1 of a 21-day cycle, for 4-6 cycles.
Study NCT02996214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 75 mg/m\^2, given on day 1 of a 21-day cycle, for 4-6 cycles.
Study NCT03131544 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Guided Transrectal Periuretheral Transitional Zone Ablation
Description: Patients will undergo an MRI guided transrectal ablation of tissue within the periuretheral transitional zone.
Study NCT04831463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Increasising Health Awareness Program for Immigrant Men
Description: The IHAPIM program is a health promotion intervention. The aim of intervention improve health perception and responsibilitiy
Study NCT03844217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macimorelin 0.5mg/kg body weight
Description: oral Macimorelin stimulation test with the dose of 0.5mg/kg body weight Macimorelin
Study NCT03844217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macimorelin 0.75mg/kg body weight
Description: oral Macimorelin stimulation test with the dose of 0.75mg/kg body weight Macimorelin
Study NCT02465294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: This group will receive the Lactobacillus probiotic, which will be taken as a capsule once daily for 12 weeks.
Study NCT02465294 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention
Description: All participants will participate in weekly group meetings of 15 to 20 participants for a facilitated discussion of specific nutritional, behavioral, and physical activity topics chosen to promote weight loss.
Study NCT04530630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIKTARVY 50Mg-200Mg-25Mg Tablet
Description: A three-drug fixed dose combination tablet containing 50mg of bictegravir, 200mg of emtricitabine, and 25mg of tenofovir alafenamide.
Study NCT02124668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: oral
Study NCT03351075 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard physical therapy program
Description: Mobilisations, stretching, scar tissue treatment and exercises~* Start immediately after surgery, sessions are individual and take 30 minutes~* Intensive phase (4 months): 1-2x/week~* Maintenance phase (8 months, 3 sessions): 6, 8 and 12 months post-surgery
Study NCT03351075 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard physical therapy program
Description: Mobilisations, stretching, scar tissue treatment and exercises~* Start immediately after surgery, sessions are individual and take 30 minutes~* Intensive phase (4 months): 1-2x/week~* Maintenance phase (8 months, 3 sessions): 6, 8 and 12 months post-surgery
Study NCT03351075 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modern educational program
Description: This modern neuroscience educational approach is suited to explain more complex issues associated with pain such as the involvement of peripheral and central mechanisms, neuroplasticity and pain behaviour.~* Sessions are individual and take 30 minutes, in addition to the standard physical therapy sessions~* 3 sessions during week 1-2, 3 booster sessions at 6, 8 and 12 months post-surgery
Study NCT03351075 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional biomedical educational program
Description: Traditional educational interventions are applied according to the biomedical model. This means that the patient's pain experience is explained from a tissue (injured versus healthy tissue) and biomechanics perspective~* Sessions are individual and take 30 minutes, in addition to the standard physical therapy sessions~* 3 sessions during week 1-2, 3 booster sessions at 6, 8 and 12 months post-surgery
Study NCT03022994 — intervention group
Intervention type: OTHER
Intervention: Duodenum and rectum examination
Description: All subjects will undergo upper gastrointestinal endoscopy and proctoscopy. In addition, it will be also evaluated duodenal and rectal biopsies.
Study NCT02198469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Er:YAG AFL-PDT
Description: Er:YAG AFL was performed with 350 µm ablation depth, level 1 coagulation, 22% treatment density, and a single pulse. MAL cream was then applied under occlusion for 3 hrs and illuminated with a red light-emitting diode light at 37 J/cm2.
Study NCT02198469 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MAL-PDT
Description: a 1-mm thick layer of MAL (16% Metvix® cream, PhotoCure ASA, Oslo, Norway) was applied to the lesion and to 5 mm of surrounding healthy tissue. The area was covered with an occlusive dressing (Tegaderm, 3M, Saint Paul, MN, US) for 3 hours, after which the remaining cream was removed with saline gauze, and the red fluorescence of porphyrins was visualized with Wood's light. Each treatment area was then separately illuminated with red light-emitting diode (LED) lamps (Aktilite CL128; Galderma, Bruchsal, Germany) with peak emission at 632 nm and total light dose of 37 J cm-2. Areas scheduled to receive MAL-PDT received the second treatment 7 days later.
Study NCT02002845 — intervention group
Intervention type: DEVICE
Intervention: robotic surgery using the da Vinci Surgical System
Study NCT04194710 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Autologous Cytokine Rich Serum
Description: Proteins, called cytokines, released from blood platelets and leukocytes, play an important role in the repair and regeneration of the injured tissue that causes lateral epicondylitis.~Autologous Cytokine Rich Serum is prepared by the medical devise Q-Cytokine (CE MED31489) from patient's blood. The company Tecnologia Regenerativa Qrem S.L., with licence number 7096-PS from Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), is the manufacturer of this product. Q-Cytokine is a lab-in-a-box devise, and consist of an automatic centrifuge and a sterile disposable kit. After 9 steps of centrifugation, that take place in 36 minutes, Cytokine Rich Serum is obtained. This Cytokine Rich Serum is then injected to the epicondyle.~Patients randomized to this treatment will receive 1 injections of Autologous Cytokine Rich Serum right after randomization and another one after 15 days.~This process will take place at outpatient clinics.
Study NCT03606655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kava
Description: Kava: 75 mg three times daily (3 capsules)
Study NCT02584023 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lung ultrasound
Description: Lung ultrasound on both hemithorax in supine position
Study NCT02584023 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Lung ultrasound
Description: Lung ultrasound on both hemithorax in supine position
Study NCT04194710 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic Resection
Description: Surgical treatment of resection by arthroscopy is the standard treatment for chronic epicondylitis. The surgery is performed in the operating room under local anesthesia and lasts approximately 30 minutes. During the surgery, the doctor accesses the tendon by arthroscopy to perform an exeresis of the degenerated tendon. After the operation, the patient is directed to the recovery room where the responsible doctor will perform a physical examination and examination before leaving the center.~This process will take place at the major ambulatory surgery center of the investigator's hospital.
Study NCT02465294 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Behavioral lifestyle intervention
Description: All participants will participate in weekly group meetings of 15 to 20 participants for a facilitated discussion of specific nutritional, behavioral, and physical activity topics chosen to promote weight loss.
Study NCT02465294 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This group will receive the placebo and will be taken as a capsule once daily for 12 weeks. The placebo will contain encapsulated potato starch which is used the matrix in the probiotic supplements.
Study NCT02465294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood Test
Description: All subjects will have blood tests performed.
Study NCT02465294 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Blood Test
Description: All subjects will have blood tests performed.
Study NCT02465294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: This group will receive the blend of Bifidobacterium and Lactobacillus probiotic, which will be taken as a capsule once daily for 12 weeks.
Study NCT04122144 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENHANCED -SPS intervention
Description: a) Enhanced VL counseling: Explanation of VL \& Importance of VL suppression,assessment of adherence, counseling based on VL result and schedule for next VL testing and the role of VL and the MTCT risk; b).Standardized peer mother support: includes training of peer mothers on mandatory enhanced VL counseling during the routine peer counseling and education, follow up of mothers and continued adherence counseling and disclosure support and bi-weekly phone calls to mothers to provide VL counseling and follow up
Study NCT03925350 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: 300 mg PO daily
Study NCT03425695 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CheseeTM Diode Laser
Description: low level laser therapy was utilized adjunct with free gingival graft.
Study NCT03425695 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CheseeTM Diode Laser
Description: low level laser therapy was utilized adjunct with free gingival graft.
Study NCT03425695 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Clinical examination
Description: The shrinkage of the graft area was calculated according to the differences between the graft area at baseline, 1st, 3rd, and 6th months.~Epithelization was determined via bubbling test by using 3% hydrogen peroxide (H2O2) at 7, 14, 21, and 28 days after surgery.
Study NCT01524926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizotinib (PF-02341066)
Description: For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of 500, 400 or 250 mg/day depending on toxicitie; for patients younger than 15yo, 280 mg/m²/dose BID, with reductions allowed to 80% as first reduction and to 60% as second reduction respectively of the initial dose.
Study NCT02708004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aprocitentan
Description: Formulated in capsules in 2 different strengths; 2 capsules per day
Study NCT02708004 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching active drug
Study NCT03083106 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Elevoplasty
Description: The Elevo™ Kit Snoring Intervention Device is designed to facilitate deployment of the Elevo™ suture implant into the submucosal tissue of the soft palate via a minimally invasive, outpatient procedure performed by an otolaryngologist in a medical office setting.